Recombinant Antibodies for Diagnostics and Research

Antibody generation and production
Services and custom solutions
Licensing and partnerships
bt_bb_section_bottom_section_coverage_image
https://abcalis.com/wp-content/uploads/2021/12/a_right_white_shadow_300_300.png

Latest News

Abcalis has been awarded with the ECEAE Prize for animalfree antibodies. Our co-founder Dr. Esther Wenzel gladly represented us at the prize ceremony in Brussels.

Abcalis participated in a worldwide study on the efficacy of SARS-CoV-2 cross-vaccinations

Abcalis' antibody against anti-SARS-CoV-2 Spike Protein S1 (RBD) binds to Omicron variant

Antibody generation & production

Antibody generation & production

Selected via phage display
Affinity maturation

Affinity maturation

Improved affinity and binding characteristics
Antibody format conversion

Antibody format conversion

Host species of choice, Fc-engineering, protein tag fusion
Naïve library generation

Naïve library generation

Representation of the complete resting state antibody repertoire

SERVICESWe find the best suitable Reagents for You

Tailor-made antibody services guarantee full
versatility and performance for your setup.
https://abcalis.com/wp-content/uploads/2021/12/ab_right_white_shadow_600_600.png
https://abcalis.com/wp-content/uploads/2021/12/ab_left_white_shadow_300_300.png

PRODUCTSHighly specific and sequence defined recombinant antibodies

Multiclonals™
An animal free recombinant antibody mix for unlimited reproducibilty.
SARS-CoV-2
anti-S1-protein (Alpha, Beta, Gamma, Delta) and anti-N-protein antibodies
Monoclonals

Monoclonals

Portfolio of monoclonal antibodies against a variety of different targets.
Custom formats

Custom formats

Custom antibody formats for specialized and novel applications.
https://abcalis.com/wp-content/uploads/2021/12/a_left_white_shadow_300_300.png

BENEFITSStay competitive

Abcalis® vegan antibodies and services help diagnostic companies and researchers worldwide improve the quality, reliability and continuity of their tests and experiments.
bt_bb_section_top_section_coverage_image

Our Customers and Partners

https://abcalis.com/wp-content/uploads/2021/12/partner_logo_01_sw.png
https://abcalis.com/wp-content/uploads/2021/12/customer_logo_01_sw.png
https://abcalis.com/wp-content/uploads/2021/12/partner_logo_02_sw.png
https://abcalis.com/wp-content/uploads/2022/06/partner_logo_04_sw.png
https://abcalis.com/wp-content/uploads/2021/12/partner_logo_03_sw.png
https://abcalis.com/wp-content/uploads/2021/12/customer_logo_02_sw.png
https://abcalis.com/wp-content/uploads/2021/12/product_sarscov2_monoclonals_web_02.jpg
https://abcalis.com/wp-content/uploads/2020/04/hero_single_service-3.jpg
https://abcalis.com/wp-content/uploads/2021/12/services_web_01.jpg
https://abcalis.com/wp-content/uploads/2021/12/lab_web_01.jpg
https://abcalis.com/wp-content/uploads/2021/12/abcalis_collection_mobile_01-min.png

ADVANTAGESMaking full use of sequence defined reagents

All Abcalis® antibodies are sequence defined and thereby truly immortalized in the form of digital data. Even if all biological samples are lost, the antibodies can still be recreated.
New level of product quality
Animal-free and sustainable
Scalable batch sizes
Unlimited reproducibility
Lower risk and QC costs
Regulatory future-proof
https://abcalis.com/wp-content/uploads/2021/12/a_right_dark_shadow_300_300.png
https://abcalis.com/wp-content/uploads/2021/12/ab_left_dark_shadow_300_300-1.png

MISSIONOver 30 Years of Experience in Phage Display Technology

Our mission is to ensure antibodies sourced from animals will become a practice of past times.
Multi-generational libraries
High-quality results
Led by expert specialists
Nobel Prize technology
https://abcalis.com/wp-content/uploads/2021/12/home_abcalisteam_05_1.jpg
https://abcalis.com/wp-content/uploads/2021/12/home_abcalisteam_03.jpg
https://abcalis.com/wp-content/uploads/2021/12/home_abcalisteam_01.jpg
https://abcalis.com/wp-content/uploads/2021/12/home_abcalisteam_04.jpg
https://abcalis.com/wp-content/uploads/2021/12/abcalis_collection_mobile_02-min.png

Press and Media

https://abcalis.com/wp-content/uploads/2021/12/press_logo_01_sw.png
https://abcalis.com/wp-content/uploads/2021/12/press_logo_02_sw.png
https://abcalis.com/wp-content/uploads/2021/12/press_logo_05_sw.png
https://abcalis.com/wp-content/uploads/2021/12/press_logo_03_sw.png
https://abcalis.com/wp-content/uploads/2022/01/press_logo_07_sw.png

Awards and Prizes

https://abcalis.com/wp-content/uploads/2022/03/press_logo_09_sw.png
https://abcalis.com/wp-content/uploads/2022/01/press_logo_06_sw.png
https://abcalis.com/wp-content/uploads/2021/12/press_logo_04_sw.png
https://abcalis.com/wp-content/uploads/2022/11/grunderpreis_2022.gif
https://abcalis.com/wp-content/uploads/2022/01/press_logo_08_sw.png

Funding and Support

https://abcalis.com/wp-content/uploads/2022/11/logo-exist-smol.gif
https://abcalis.com/wp-content/uploads/2022/11/logo-esf-rgb.gif
https://abcalis.com/wp-content/uploads/2022/11/bmwi_logo-crop.gif
https://abcalis.com/wp-content/uploads/2022/11/logo_bioassembler_smol.jpg
https://abcalis.com/wp-content/uploads/2022/11/eu-funding-smol2.gif
bt_bb_section_bottom_section_coverage_image
WordPress Cookie Plugin by Real Cookie Banner